"Hemodialysis patients have plasmatic hypercoagulability and decreased fibrinolytic vulnerability: role of carbon monoxide." by Ryan W. Matika

Selected Works of Machaiah Madhrira, MD, MPH

Article

Hemodialysis patients have plasmatic hypercoagulability and decreased fibrinolytic vulnerability: role of carbon monoxide.

Asaio Journal (2014)

Ryan W. Matika, University of Arizona
Vance G. Nielsen, University of Arizona
Evangelina B. Steinbrenner, University of Arizona
Amy N. Sussman, University of Arizona
Machaiah Madhrira, University of Arizona

Link

Disciplines

Medicine and Health Sciences,
Cardiology,
Surgery and
Internal Medicine

Publication Date

November 1, 2014

DOI

10.1097/MAT.0000000000000144

Citation Information

Ryan W. Matika, Vance G. Nielsen, Evangelina B. Steinbrenner, Amy N. Sussman, et al.. "Hemodialysis patients have plasmatic hypercoagulability and decreased fibrinolytic vulnerability: role of carbon monoxide." Asaio Journal Vol. 60 Iss. 6 (2014) p. 716 - 721
Available at: http://works.bepress.com/machaiah-madhrira/24/